Target intelligence / Profile preview

Beta-1,4-galactosyltransferase 6 (B4GALT6)

Target: B4GALT6
Molecular classification: Enzyme, Glycosyltransferase, Type II membrane protein

Overview

Beta-1,4-galactosyltransferase 6 (B4GALT6) is an enzyme involved in the biosynthesis of glycosphingolipids, specifically catalyzing the transfer of galactose from UDP-galactose to glucosylceramide to produce lactosylceramide, a precursor for gangliosides and other complex glycolipids. B4GALT6 is a type II transmembrane glycoprotein localized to the Golgi apparatus and plays a critical role in neuronal maturation and myelin formation. Mutations in B4GALT6 are associated with neurodevelopmental and connective tissue disorders[1][2][5][7].

Other names: Beta4GalT-VIUDP-Gal:glucosylceramide beta-1,4-galactosyltransferaseUDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6Glucosylceramide beta-1,4-galactosyltransferaseLactosylceramide synthaseBeta-1,4-GalTase 6beta4Gal-T6LacCer synthaseUDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6UDP-Gal:BetaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6[1][7][5]

Mechanism of action

Not applicable/no drugs documented; theoretical inhibition would impact glycosphingolipid biosynthesis

Biological functions

Glycosphingolipid biosynthesisSphingolipid metabolismTransfer of galactose to glucosylceramide (formation of lactosylceramide)Biosynthesis of gangliosides, which are important for neuronal maturation and axonal/myelin formation[1][7][2][3]

Disease associations

Spinal muscular atrophy with progressive myoclonic epilepsyEhlers-Danlos syndrome, spondylodysplastic type 2Other conditions involving glycosphingolipid metabolism[1]

Safety considerations

Disruption may affect neuronal development and function due to impaired glycosphingolipid/ganglioside biosynthesis[1][7]

Interacting drugs

None documented in current search results; no approved drugs directly targeting B4GALT6

Biomarkers

No clinical biomarkers for patient selection or monitoring identified in current search results

Beyond the preview

Go deeper on Beta-1,4-galactosyltransferase 6 (B4GALT6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-1,4-galactosyltransferase 6 (B4GALT6).

Explore the full profile